<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ImmunoGPT</title>
    <style>
        body {
            margin: 0;
            font-family: 'Arial', sans-serif;
            background: linear-gradient(to right, #1f3b5e, #000000);
            color: white;
        }

        nav {
            background-color: rgba(0, 0, 0, 0.8);
            padding: 20px;
            position: sticky;
            top: 0;
            display: flex;
            justify-content: space-around;
            align-items: center;
        }

        nav a {
            color: white;
            text-decoration: none;
            padding: 10px 20px;
            font-size: 18px;
        }

        nav a:hover {
            background-color: #28a745;
            border-radius: 4px;
        }

        section {
            padding: 40px;
            max-width: 1200px;
            margin: 0 auto;
        }

        header {
            text-align: center;
            margin-top: 50px;
        }

        h1 {
            font-size: 4rem;
        }

        .content {
            background: rgba(0, 0, 0, 0.7);
            border-radius: 8px;
            padding: 30px;
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.5);
        }

        footer {
            background-color: rgba(0, 0, 0, 0.8);
            text-align: center;
            color: white;
            padding: 20px;
            position: fixed;
            bottom: 0;
            width: 100%;
        }

        .button {
            background-color: #28a745;
            color: white;
            padding: 10px 20px;
            text-decoration: none;
            border-radius: 4px;
            font-size: 18px;
        }

        .button:hover {
            background-color: #218838;
        }

        .gradient-background {
            background: linear-gradient(45deg, #1f3b5e, #28a745);
            padding: 20px;
            border-radius: 8px;
        }

    </style>
</head>
<body>

<nav>
    <a href="index.html">Home</a>
    <a href="founder.html">Founder</a>
    <a href="immunogpt.html">ImmunoGPT</a>
    <a href="simulation.html">Simulate</a>
</nav>

<!-- Home Page -->
<section id="home">
    <header>
        <h1>Welcome to ImmunoGPT</h1>
        <p>The Future of Personalized Immune Response Simulation</p>
    </header>
    <div class="content">
        <h2>What is ImmunoGPT?</h2>
        <p>ImmunoGPT uses advanced artificial intelligence to design personalized immune responses to cancer, infections, and other diseases. With cutting-edge research in genomics and immunology, we create precise simulations of how a patient’s immune system would react to specific diseases, helping guide therapies and treatments.</p>
        <a href="immunogpt.html" class="button">Learn More</a>
    </div>
</section>

<!-- Founder Page -->
<section id="founder">
    <header>
        <h1>Meet the Founder</h1>
    </header>
    <div class="content">
        <h2>Avani Agarwal</h2>
        <p>Avani Agarwal, the visionary behind ImmunoGPT, is a driven researcher and innovator. With a background in AI-driven biomedical research, she aims to revolutionize the field of immunotherapy. Avani has worked with top institutions such as Harvard, Yale, and Massachusetts General Hospital, developing innovative models for drug discovery and personalized medicine.</p>
        <p>Her passion for integrating AI with medicine stems from a deep desire to understand the complexities of the human immune system and the future of healthcare.</p>
        <a href="index.html" class="button">Back to Home</a>
    </div>
</section>

<!-- ImmunoGPT Page -->
<section id="immunogpt">
    <header>
        <h1>What is ImmunoGPT?</h1>
    </header>
    <div class="content gradient-background">
        <h2>Introducing ImmunoGPT</h2>
        <p>ImmunoGPT is a groundbreaking model that simulates immune responses based on personalized data, including genomic sequencing and protein structures. By leveraging the power of large-scale AI models, ImmunoGPT provides insights into the optimal immune therapy for a given patient, enabling more targeted and effective treatments.</p>
        <p>This model can be used for a wide range of applications, from cancer therapy to infectious disease management, offering a new level of precision in immunology.</p>
        <a href="simulation.html" class="button">Start Simulation</a>
    </div>
</section>

<!-- Immune Response Simulation Page -->
<section id="simulation">
    <header>
        <h1>Simulate Your Immune Response</h1>
    </header>
    <div class="content">
        <h2>Enter Your Tumor and Mutation Data</h2>
        <form id="simulation-form">
            <label for="mutation">Mutation Type:</label>
            <input type="text" id="mutation" name="mutation" placeholder="e.g., KRAS, TP53" required>
            <label for="tumor-type">Tumor Type:</label>
            <input type="text" id="tumor-type" name="tumor-type" placeholder="e.g., Lung, Colon" required>
            <label for="mutation-load">Mutation Load (Number of mutations):</label>
            <input type="number" id="mutation-load" name="mutation-load" required>
            <button type="submit" class="button">Simulate Response</button>
        </form>
        <div id="simulation-result">
            <h3>Immune Response Prediction</h3>
            <p id="response-text">Enter data to predict the immune response.</p>
        </div>
    </div>
</section>

<footer>
    <p>&copy; 2025 ImmunoGPT | All Rights Reserved</p>
</footer>

<script>
    const dummyData = {
        "KRAS-G12D": {
            lung: "High immunogenicity. Checkpoint inhibitor + MEK inhibitor combo advised.",
            colon: "Low response. Potential for CAR-T cell targeting G12D epitope.",
        },
        "TP53-R175H": {
            lung: "Strong response. Synthetic neoantigen vaccine feasible.",
            breast: "Intermediate immunogenicity. Monitor p53 pathway reactivation.",
        },
        "BRAF-V600E": {
            melanoma: "Very high immunogenicity. Dual BRAF/MEK inhibition + PD-1 therapy recommended.",
            colon: "Limited response. Consider immunogenicity enhancement strategies.",
        },
        "EGFR-L858R": {
            lung: "Targetable. EGFR TKI with immunotherapy in late-stage trials.",
            brain: "Low immune visibility. Use with BBB-penetrating checkpoint blockers.",
        },
        "PIK3CA-H1047R": {
            breast: "Moderate immune engagement. PI3Kα-specific therapy + immune adjuvants advised.",
            ovarian: "Low immunogenicity. Dual pathway targeting under study.",
        }
    };

    document.getElementById("simulation-form").addEventListener("submit", function(event) {
        event.preventDefault();

        const mutation = document.getElementById("mutation").value.toUpperCase().trim();
        const tumorType = document.getElementById("tumor-type").value.toLowerCase().trim();
        const mutationLoad = document.getElementById("mutation-load").value.trim();

        let immuneResponse = "Sorry, we don't yet support this mutation-tumor combination.";

        if (dummyData[mutation] && dummyData[mutation][tumorType]) {
            immuneResponse = `${dummyData[mutation][tumorType]} Mutation Load: ${mutationLoad}.`;
        }

        document.getElementById("response-text").textContent = immuneResponse;
    });
</script>



</body>
</html>
